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Abstract
Background: Schistosoma mansoni is a parasite of profound medical importance. Current control focusses on mass
praziquantel (PZQ) treatment of populations in endemic areas, termed Preventative Chemotherapy (PC). Large-scale
PC programmes exert prolonged selection pressures on parasites with the potential for, direct and/or indirect,
emergence of drug resistance. Molecular methods can help monitor genetic changes of schistosome populations
over time and in response to drug treatment, as well as estimate adult worm burdens through parentage analysis.
Furthermore, methods such as in vitro drug sensitivity assays help phenotype in vivo parasite genotypic drug efficacy.
Methods: We conducted combined in vitro PZQ efficacy testing with population genetic analyses of S. mansoni
collected from children from two schools in 2010, five years after the introduction of a National Control Programme.
Children at one school had received four annual PZQ treatments and the other school had received two mass treatments
in total. We compared genetic differentiation, indices of genetic diversity, and estimated adult worm burden from
parasites collected in 2010 with samples collected in 2005 (before the control programme began) and in 2006 (six
months after the first PZQ treatment). Using 2010 larval samples, we also compared the genetic similarity of those with
high and low in vitro sensitivity to PZQ.
Results: We demonstrated that there were individual parasites with reduced PZQ susceptibility in the 2010 collections, as
evidenced by our in vitro larval behavioural phenotypic assay. There was no evidence, however, that miracidia showing
phenotypically reduced susceptibility clustered together genetically. Molecular analysis also demonstrated a significant
reduction of adult worm load over time, despite little evidence of reduction in parasite infection intensity, as measured by
egg output. Genetic diversity of infections did not reduce over time, despite changes in the genetic composition of the
parasite populations.
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Conclusions: Genotypic and phenotypic monitoring did not indicate a selective sweep, as may be expected if
PZQ treatment was selecting a small number of related “resistant” parasites, but there was evidence of genetic
changes at the population level over time. Genetic data were used to estimate adult worm burdens, which unlike
parasite infection intensity, showed reductions over time, suggesting the relaxation of negative density-dependent
constraints on parasite fecundity with PZQ treatment. We thereby demonstrated that density-dependence in
schistosome populations may complicate evaluation and monitoring of control programmes.
Keywords: Density-dependence, Neglected tropical diseases, Schistosomiasis, Population genetics, Drug resistance,
Praziquantel
Background
Neglected tropical diseases (NTDs) are caused by a group
of infectious agents that, almost exclusively, affect the rural
poor in developing countries [1]. Schistosomiasis, caused
by parasitic flatworms, is a disease of profound medical
and veterinary importance, affecting over 240 million
people, with over 90% of these in sub-Saharan Africa (SSA)
[2]. National successes in the control of this important
disease have been realised through mass drug adminis-
tration (MDA) of affected communities, using the current
drug of choice, praziquantel (PZQ) [3]. For example, the
Schistosomiasis Control Initiative, established in 2002,
has assisted Ministries of Health across SSA to deliver
more than 250 million PZQ treatments to date. These
control programmes, termed preventative chemotherapy
(PC), have had impressive effects on reducing schistosom-
iasis prevalence, infection intensity and associated mor-
bidity [4]. However, only 21% of people estimated to need
PZQ received it in 2014 [5]. Commitments such as the de-
velopment of a World Health Organization (WHO) Road-
map for NTD implementation [6], the inclusion of NTD
control in the sustainable development goals and large
scale PZQ drug donations and in particular the promise
by Merck KGaA to donate 250 million PZQ tablets per
year from 2016 [3], have all aided the continued scaling
up of such programmes, with the promise of an agenda
for elimination of schistosomiasis as a public health prob-
lem in some areas [6]. The implementation of such large-
scale preventative chemotherapy, however, is likely to be
exerting strong and prolonged evolutionary selection pres-
sure on the parasites [7]. These may cause selection to-
wards reduced drug efficacy, but also potentially changes
in life history trade-offs affecting, for example, host use,
transmission rates and/or parasite virulence. Such select-
ive pressures will increase as the fraction of the parasite
population undergoing chemotherapy increases and refu-
gia decrease [7].
Clinical efficacy of PZQ is measured as the egg reduc-
tion or cure rates and recent data around Lake Victoria
have raised concerns that there may be a real possibility
of reduced efficacy in communities with a more inten-
sive history of PZQ treatment [8, 9]. However, variations
in PZQ efficacy depend on both host and parasite fac-
tors, and in the absence of individual level longitudinal
data before and immediately after PZQ treatment over
several years, or baseline data from before PC, it is difficult
to know whether heterogeneity in treatment response is
static or changing over time, as would be expected if PZQ
resistance was developing. Monitoring of drug efficacy
over time in treatment programmes is complicated since
ethical considerations mean that if there is testing for, and
detection of, parasites immediately following treatment,
further treatment is necessary, and thus selected sites will
not mimic the treatment history of the rest of the control
programme. Moreover, several features of schistosome
epidemiology, together with the lack of sensitivity of
current diagnostic tools [10], means monitoring the im-
pact of treatment on parasitological indicators is itself
complex, not least because it relies on indirect mea-
sures of egg output, rather than adult worm burdens.
For example, density-dependence is a common feature
of macroparasite life-cycles that can influence parasite
fecundity, survival and establishment and can act at
multiple points of the macroparasite life-cycle. At high
parasite population densities, negative density depend-
ence tends to restrict population growth and contribute
to the stability of these populations. Interventions that
lead to a reduction in parasite populations could thereby
be predicted to cause a relaxation of density-dependent
restrictions, increasing per-capita rates of reproduction or
survival, thereby potentially contributing to population
persistence and resilience, and complicating the monitor-
ing of chemotherapy success [11].
A key problem in monitoring for PZQ resistance is
that though such resistance can be selected for in the la-
boratory, its molecular basis has not yet been ascer-
tained, and thus genotypic markers for PZQ resistance
are currently not available. However, at the individual
level, in vitro phenotypic monitoring of larval behaviour
when exposed to PZQ has been developed to monitor
the phenotypic status of individual parasites, with in vitro
PZQ susceptibility correlating to in vivo treatment suc-
cess [12]. In addition, genetic monitoring using neutral
markers such as microsatellites can identify clusters of
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genetically related parasites indicative of population
level changes in parasites [13]. Thus, monitoring the
impact of preventative chemotherapy on parasite popu-
lation genetics, and in particular associations with PZQ
susceptibility phenotypes, may be of considerable import-
ance to the continued success of control programmes.
Moreover, population genetic studies performed on the
accessible miracidial larval stage, enable estimation of
adult worm burden and egg per worm output using par-
entage analysis, which cannot be measured by parasito-
logical field methods alone. The precise nature of negative
fecundity density dependence in natural human schisto-
some populations is not well understood, since the only
data that exists is from a single autopsy study [14], and
there are no data on the response of this relationship to
preventative chemotherapy.
Our previous work, on the Schistosoma mansoni para-
site population genetics in two schools in the Lake
Victoria region in Tanzania [13], was one of the first
studies to make use of then recently developed techniques
for parasite collection, storage and DNA amplification of
schistosome miracidia allowing large numbers of individ-
ual miracidia to be analysed directly from stools from in-
fected children [15]. Thus this represented one of the
earliest baseline field collections of schistosome miracidia
before widespread control of schistosomiasis in sub-
Saharan Africa began. After collection of baseline data in
April 2005, Bukindo and Kisorya Primary schools received
school-based mass treatment of PZQ in June of the same
year as part of the first treatment of the National Schisto-
somiasis Control Programme, and parasite samples were
collected from children at the same schools six months
later. Despite the large parasite refugia (in snails, un-
treated mammals and untreated people), we demonstrated
a significant decrease of allelic richness and heterozygosity
of the parasites after only one round of PC including in
miracidia isolated from untreated children [13]. Such a
community-wide effect on untreated children was inter-
preted as either a protective immune effect induced by the
mass treatment of the population, or more worryingly evi-
dence of selection for potentially drug-resistant parasites.
An alternative explanation is that the changes observed
were not due to the treatment itself, but to other factors,
such as environmental differences between the years of
the study, or a combination of both. To date, none of
these hypotheses have been confirmed in the natural en-
vironment in Tanzania, and studies in other places have
reported varying effects of PZQ infection on S. mansoni
ranging from no evidence of genetic change over time
(e.g. in Senegal [16], or Kenya [17]) to clear effects of de-
creasing diversity and effective population size in response
to treatment (e.g. in Brazil, [18]).
The aim of this study was to return to Bukindo and
Kisorya Primary schools to measure the effect of five years
of the National Schistosomiasis Control Programme
Tanzania on the phenotype and genotype of the S.
mansoni parasite population. Using the same experi-
mental set-up as the baseline study, we compared gen-
etic differentiation and indices of genetic diversity in
2010 samples with baseline samples collected in 2005
and 2006. We performed in vitro tests of PZQ sensitivity
and, for the first time in a natural population, compared
the genetic profiles of individual miracidia with low or
high susceptibility to PZQ in vitro, to quantify genetic dif-
ferentiation between them. Finally, we assessed evidence
of the existence of density dependence in schistosome
populations using genetic parentage analysis.
We predicted that: (i) the genetic composition of para-
site populations may change over time and in response
to PZQ treatment; (ii) in vitro PZQ testing can identify
individual parasites with reduced sensitivity to PZQ and
that population genetics can ascertain if those with re-
duced sensitivity are closely related to each other; (iii)
the genetic diversity of parasite populations will further
reduce with additional PZQ treatment; and (iv) adult
worm burdens are non-linearly related to egg output and
that this relationship may be affected by PZQ treatment.
Methods
Study area, children surveyed and parasite samples
collected
As reported elsewhere [13], S. mansoni miracidia were
collected from children aged 7–11 years old at two
schools in close proximity to Lake Victoria, Tanzania, in
April 2005, six months prior to the first National Schis-
tosomiasis Control Programme mass school based treat-
ment with PZQ, and again one year later in April 2006.
In 2005, miracidia were collected from 38 children at
Bukindo Primary School (Ukewere District, Ukewere
Island, Mwanza Region) and 42 children from Kisorya
Primary School (Bunda District, Mainland, Mara Region),
and in 2006 from 18 children at Bukindo Primary School
and 29 children from Kisorya Primary School (Additional
file 1: Figure S1). The straight-line geographical distance
between the villages was approximately 18 km. Bukindo
Primary School received PC with PZQ in 2005, 2006,
2007 and 2009, while children from Kisorya Primary
School were treated with PZQ in 2005 and 2007 only due
to funding restrictions. The two schools were re-visited in
July 2010 and at this time the study was explained to the
children and they were assured that participation was vol-
untary. Sixty randomly selected children at each school
who provided oral consent were assayed for S. mansoni
infection by Kato-Katz microscopy over three days (see
below). Following data and sample collection, all children
in both schools (including those who took place in the
survey, any children who had been asked but did not want
to take part and all other children attending school) were
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treated for schistosomiasis with PZQ (40 mg/kg) and
soil-transmitted helminths with albendazole (400 mg).
Determination of infection intensity
In order to determine the prevalence and intensity of
schistosome infection, duplicate Kato-Katz thick smears
were prepared from three individual stool samples, over
three consecutive days, from each child. The infection
intensity was expressed as eggs per gram stool (epg) and
averaged over the two slides for each day, and then over
the three days of collection. All infection data were col-
lected pre-treatment at each time point and there was
no direct measure of drug efficacy in terms of egg reduc-
tion rate or cure rate so that the selected populations
had the same treatment history as the rest of the control
programme.
Collection of S. mansoni miracidia from faecal samples
Schistosoma mansoni eggs were purified from individual
stool samples of all Kato-Katz-positive children as previ-
ously described [13, 15] and hatched to obtain individual
miracidia, which were stored on Whatman FTA cards®
(Whatman International Ltd., Maidstone, UK) until re-
quired for genetic analysis.
In vitro PZQ testing of miracidia
Samples from five children, which yielded sufficient viable
miracidia, were used to screen for susceptibility to PZQ
using an in vitro phenotypic test based on the change in
shape that occurs in susceptible S. mansoni miracidia
when they are exposed to PZQ. In brief, susceptible mira-
cidia first become tadpole and then dumbbell shaped
upon PZQ exposure, with the degree of shape change and
activity level correlated to drug susceptibility and in vivo
drug efficacy [12]. For each child, between 40 and 60 indi-
vidual miracidia were collected in 18 μl water. Using a
microscope the wildtype phenotype at baseline was
confirmed for each individual miracidium. Following
that, 2 μl of a 5 × 10−6 M PZQ solution (Sigma-Aldrich,
Gillingham, UK) were added, in order to expose every
miracidium to a final PZQ concentration of 1 × 10−6M
in 20 μl total volume. After 5 min incubation at room
temperature, resistance levels of individual miracidia were
microscopically classified according to observed phenotyp-
ical changes: “less susceptible” - normal shape following
PZQ exposure, “intermediate susceptibility/resist-
ance” - tadpole shape, “fully susceptible” - dumbbell
shape [12], and stored on FTA Whatman cards as de-
scribed above.
Microsatellite analysis of individual miracidia
Molecular analysis was carried out on up to 20 miracidia
per child from the 2010 collections depending on the in-
fection intensity of the child. We replicated the identical
methodologies of the original 2005 and 2006 surveys in
order that the data were directly comparable [13], since
the original miracidial samples were no longer available
for re-analysis. In brief, DNA preparation was carried out
on the Whatman cards as per the manufacturers protocol
(Whatman FTA cards®). PCR was carried out using the
previously published multiplex assay using seven pairs of
microsatellite primers [15], namely SMD28, SMDA28,
SDM25, SMD89, CA11-1, SMS9-1 and SMU31768. For-
ward primers were labelled using 6-FAM, PET, VIC and
NED dyes. Microsatellite sizing was performed on the
same ABI Prism 3730 Genetic Analyser with a LIZ-500
size standard (Applied Biosystems, Cheshire, UK) as the
2005 and 2006 samples.
Statistical analyses
Prevalence and infection intensity of schistosomiasis in
2005–2010
Estimates of prevalence and infection intensity were cal-
culated using data from the 2010 survey of approxi-
mately 60 children at each school, and were compared
with estimates of prevalence and infection intensity from
2005 and 2006. These were based on larger surveys of
approximately 200 children per school undertaken as
part of the National Schistosomiasis Control programme
monitoring and evaluation (Schistosomiasis Control
Initiative), unpublished data [13]. To compare the in-
fection intensity at the two schools in 2010 we used a
two-sample t-test with equal variances of logarithmically-
transformed data.
Population genetic analyses
Allele sizes were calculated in Genemapper (v4) and
manually checked using the same bin sizes as for the
2005 and 2006 samples. Subsequent analysis was restricted
to miracidia with at least 4 allele calls. There was an aver-
age of 7% missing data present per locus but no evidence
that there were systematic differences between the years in
the amount of missing data (χ2 = 1.04, df = 2, P = 0.41). All
population genetic measures were calculated at an infrapo-
pulation level (where all the parasites within a host are
considered as a single infrapopulation), except where expli-
citly stated.
Parentage analysis, estimates of adult worm burden, and
reproductive success of adult worms
The estimation of full-relationships between the mira-
cidia of individual children was carried out separately
using Colony version 2.0.6.1 [19]. Colony implements a
maximum likelihood algorithm when comparing differ-
ent sibship configurations and also allows for genotyping
error [20]. Genotyping error was calculated from repeat
amplifications of 30 adult worms (from which multiple
DNA samples could be obtained) and had a mean value
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of 3.6% (range 0–7%). The definition of genotyping error
included alleles which did not amplify (missing data).
Colony allows for a number of assumptions regarding
mating behaviour of parental worms, and we assumed
that adult worms were monogamous, but that clonal
worms could be present, as suggested by recent analysis
of the mating behaviour of schistosome system [21].
Sibship relationships are then used to estimate the
number of unique adult worm genotypes present. To
investigate the presence of density dependent fecundity,
the worm burdens of individual children estimated
using Colony, together with their individual infection
intensity, were used to estimate the parasite reproduct-
ive success, measured as the mean number of eggs per
worm pair.
Differences between parasite within-child infrapopula-
tions collected at Bukindo and Kisorya schools in 2005,
2006 and 2010, in terms of their mean adult worm burden
and mean parasite reproductive rate, were investigated
using linear regression modelling in Stata Statistical Soft-
ware (StataCorp LP, USA), incorporating an interaction
term to investigate whether differences between years
were similar at the two schools under study. Child age,
sex, and miracidial sample size were used as covariates
and survey commands were used to account for within-
school clustering.
Diversity of infections
Summary statistics for expected heterozygosity (He), ob-
served heterozygosity (Ho) and allelic richness (Ar)
across each population (each child at each time point)
were created in FSTAT.2.9.3.2 [22]. Allelic richness is
suitable for comparison of samples of different sizes
since it rarefies to the smallest sample size in the data-
set, and is thus particularly useful for schistosome popu-
lation genetics where the number of miracidia collected
is in part dependent on infection intensity. The alterna-
tive approach of excluding small samples will bias the
dataset against lighter intensity infections, which might
be particularly common following successful PZQ treat-
ment. Differences in He, Ho and Ar per within-child
infrapopulation between 2005, 2006 and 2010 at each of
the two schools, were tested for using linear regression
in Stata Statistical Software (StataCorp LP, USA) using
child age, sex, school and miracidial samples size as co-
variates and using survey commands to account for
within-school clustering. An interaction term was in-
cluded to assess whether differences between years was
similar at the two schools, but was excluded from the
final model if non-significant. Differences in summary
statistics between the parasite infrapopulations at each
of the three time points were compared using a non-
parametric permutation model in FSTAT with 5000
permutations.
Population structure
As a measure of genetic distance between the parasite
populations of individual children, a matrix of Cavalli-
Sforza and Edwards’ chord distances [23] was estimated
using Powermarker [24] and visualised using a minimum
spanning network in Poppr [25] and a neighbour joining
clustering algorithm (NJ). The reliability of NJ pheno-
grams was assessed by bootstrapping over loci with 100
replications using CONSENSE [26]. Two separate analyses
were carried out, one comparing the parasite populations
of all individual children at each school and time point,
and the second restricted to those samples in 2010 which
had been assessed for in vitro PZQ susceptibility.
Hierarchical Wrights’ FST statistics measuring evidence
of genetic differentiation between years, and between chil-
dren within years were calculated for each school separ-
ately using Hierfstat [27]. P-values were calculated by
10,000 random permutations. A hierarchical analysis is
the most robust analysis as it accounts for the potential re-
latedness of miracidia within individual children, which
will tend to inflate estimates of classical Wrights’ FST
statistics [28] but separate analyses were necessary for
Bukindo and Kisorya school due to the design of the
study that meant that school and year of collection
were crossed rather than nested factors [29]. In order
to investigate the relative importance of time versus in-
dividual level and between school variation, pairwise
FST statistics were calculated between all of the para-
site infrapopulations and an average calculated for each
school/time point combination. Pairwise FST statistics
were also calculated between the 2005, 2006 and 2010
component populations (where all the miracidia at each
time point and school were pooled) for each school.
Results
Prevalence and infection intensity of schistosomiasis in
2005–2010
Prevalence and infection intensity of S. mansoni in chil-
dren aged 7 to 11 years is shown in Table 1. In 2010,
Bukindo and Kisorya Primary Schools had comparable
prevalences of 95 and 93%, respectively, but infection in-
tensities differed significantly with a mean 111 epg at
Bukindo Primary School, and 444 epg at Kisorya Primary
School (t(65) = -4.04, P = 0.001). Combining these 2010
data with previously published baseline data (2005) and
data six months after the first round of PC (2006) [13],
we observed that, although different between the schools,
infection intensities remained stable over time within both
of the study sites (Table 1), Kisorya Primary School, which
had received two mass treatments and Bukindo Primary
School, which had received four treatments in the time
period. We note that these represent pre-treatment infec-
tion levels, and do not directly measure drug efficacy since
re-infection may have occurred between survey points.
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In vitro drug-susceptibility testing of miracidia
Following screening in both schools, children with medium
(100–399 epg) or high (>400 epg) infection intensities, and
stool samples which yielded sufficient numbers of viable
miracidia within 20 min, were selected for in vitro PZQ
susceptibility testing. In 2010, five children complied with
these criteria and 35–65 miracidia per child were tested be-
ing exposed to 1 × 10−6M PZQ. As shown in Table 2, all
five children hosted worms whose offspring contained
miracidia that showed reduced in vitro susceptibility to
PZQ. A total of 234 miracidia were screened and, on aver-
age, 6% were less susceptible and retained a normal shape
following in vitro exposure to PZQ. The remaining mira-
cidia all showed clear phenotypic changes that indicated
PZQ-susceptibility, becoming tadpole shaped, however, no
dumbbell shapes (the more extreme shape change associ-
ated with greater PZQ susceptibility) were observed in any
samples tested.
Longitudinal genetic analysis of S. mansoni population
2005–2010
In 2010, miracidia were successfully stored from nine
children at Bukindo Primary School and from 18 chil-
dren at Kisorya Primary School. For the longitudinal
analysis, we analysed up to 20 miracidia per child de-
pending on availability and thus analysed 107 miracidia
from Bukindo Primary School and 245 miracidia from
Kisorya Primary School in 2010, with a school treatment
history of four and two rounds of PC, respectively, and
compared them with previously collected miracidia from
the same schools in 2005 (baseline) and 2006 (6 months
after first PC), to give a total dataset of 1936 miracidia.
The mean number of miracidia per child (±95% confidence
interval) in 2010 was 13.0 ± 0.70 which was not signifi-
cantly different from the mean number of miracidia in
2005 (12.2 ± 0.63) or 2006 (13.8 ± 0.56) (F(2,148) = 1.66, P =
0.194). One hundred and thirty miracidia, which had been
characterised as PZQ-susceptible or not by the in vitro
phenotypic assay, were analysed separately.
Parentage analysis, estimates of adult worm burden, and
reproductive success of adult worms
Adult worm burdens were estimated from genetic data
using parentage analysis. As shown in Fig. 1a, there was
a reduction in the estimated adult worm burden over
time and regression modelling confirmed that this was a
significant difference in both 2006 and 2010 compared
to the baseline collection (2006: β = -5.39, t = -5.80, P <
0.001; 2010: β = -2.46, t = -3.82, P < 0.001). The number
of miracidia was significantly associated with the esti-
mated number of worms (β = 1.56, t = 41.5, P < 0.001) but
there was no significant association of child age (t = 0.67,
P = 0.50) or sex (t = 0.86, P = 0.39) with the estimated
number of adult worms in this dataset and the fitted
Table 1 Prevalence (± 95% confidence interval, CI) and mean arithmetic infection intensity (± 95% CI) of Schistosoma mansoni at
two schools in Lake Victoria region of Tanzania in April 2005, April 2006 and July 2010
School Year Prevalence (%) (95% CI) Mean infection intensity (epg) (95% CI) No. of children surveyed (n)
Bukindo 2005 60.3 (56.6–64.1) 134.5 (114.2–154.5) 174
Bukindo 2006 77.0 (73.4–80.3) 65.5 (49.9–81.1) 160
Bukindo 2010 95.5 (88.6–98.0) 116.2 (81.2–151.2) 66
Kisorya 2005 90.4 (88.4–92.3) 421.9 (349.8–494.0) 228
Kisorya 2006 93.0 (91.2–94.8) 427.4 (352.0–502.8) 205
Kisorya 2010 92.7 (88.6–96.7) 444.4 (284.6–604.2) 41
Bukindo School received treatment in November 2005, 2007, 2008 and 2009 and Kisorya School received treatment in November 2005 and 2007 only
Table 2 In vitro praziquantel-susceptibility of individual S.mansoni miracidia isolated from 5 children in the Lake Victoria region of
Tanzania in July 2010, as measured by five minute exposure to 1 × 10−6 M PZQ and classified microscopically by shape as normal
(indicating reduced susceptibility to PZQ) or tadpole shape (sensitive to PZQ)
School Child ID PTa Individual infection
intensity (epg)
Total no. of miracidia
tested (n)
No. of less susceptible
miracidia (shape normal)
No. of susceptible
miracidia (shape
tadpole)
Percentage of less
susceptible
miracidia (95% CI)
Bukindo 1026 + 400 64 6 58 9 (2.0–16.0)
Kisorya 0012 – 1216 36 1 35 3 (0–8.6)
0017 – 2520 41 2 39 5 (0–11.7)
1002 + 330 45 4 42 7 (0–14.5)
1010 + 768 48 2 46 4 (0–9.5)
Total – – 234 15 220 5.6 (3.0–9.0)
PT indicates whether children had a previous history of PZQ treatment
a+, yes; −, no
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model explained 92% of the variation in the estimated
number of adult worms. The mean number of eggs per
adult worm pair was higher in parasite infrapopulations in
2010 than 2006 and 2005 (β = 34.3, t = 2.64, P = 0.009),
and as shown in Fig. 1b, and was higher at Kisorya than at
Bukindo school (β = 41.4, t = 4.68, P < 0.001).
Diversity of infections
There was a significant difference in genetic diversity
between parasite populations collected in 2006 and
2005, and between those collected in 2010 and 2005. As
previously reported, and shown in Fig. 2a, there was a
reduction in allelic richness between 2006 and the base-
line 2005 collection (β = -0.067, t = 5.32, P < 0.001). This
was not, however, maintained in 2010 and genetic diver-
sity was slightly higher in the 2010 collections relative
to the baseline collection (β = 0.024, t = 2.09, P = 0.04).
There was no difference in allelic richness between the
schools (β = 0.018, t = 1.75, P = 0.09). As shown in
Fig. 2b, c, similar patterns were seen in both expected
and observed heterozygosity (He 2006 compared to 2005:
β = -0.07, t = -6.46, P < 0.001; 2010 compared to 2005: β =
0.05, t = 4.46, P < 0.001; Ho 2006 compared to 2005: β
= -0.07, t = 6.62, P < 0.001; 2010 compared to 2005: β =
0.03, t = 2.62, P = 0.01), although there was a significant
lower diversity at Bukindo school (He: β = 0.024, t = 2.37,
P = 0.02; Ho: β = 0.19, t = 2.09, P = 0.04), which might re-
flect differences in infection intensities between the two
schools, despite statistical attempts to correct for the mi-
racidial sample size. Observed heterozygosity was lower
than expected heterozygosity in all populations, although
there was no evidence of change in this relationship over
time. The significant differences between years were con-
firmed by non-parametric permutation tests (Ar P < 0.001,
Ho P < 0.001, He P < 0.001).
Population structure
The genetic similarity of parasite infrapopulations collected
in the two schools at each time point are shown in Fig. 3.
There was clear clustering by year of collection, with the
later collections of 2010, in particular clustering together.
However, there was considerable overlap between infrapo-
pulations collected at the different schools particularly in
the earlier two time points. This was confirmed by
hierarchical FST statistic analysis, which indicated that
most of the variation was observed within individual
children but that there was significant more variation
between the parasite populations of children sampled in
different years than within years at both Bukindo and
Kisorya schools. At Bukindo school, FST (+ 95% confi-
dence limits) between years was 0.043 (0.025–0.057), and
within years 0.020 (0.013–0.036), while FIS was estimated
as 0.26 (0.16–0.41). At Kisorya school a similar pattern of
between years FST 0.052 (95% CI: 0.030–0.074), 0.013
(0.006–0.027) between children within years and 0.29
(0.20–0.40) between miracidia within children (FIS) was
observed. Analysis of pairwise FST statistics (Table 3), like-
wise, demonstrated a larger differentiation between years,
than between schools within years, measured both as the
component populations and as the mean of the pairwise
FST statistics for the within-child infrapopulations.
Fig. 1 Mean adult worm burden (a) and eggs per adult female worm (b) for the parasite infrapopulations of individual children, adjusted for
child age and sex and miracidial sample size, at two schools near Lake Victoria in 2005, 2006 and 2010
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Phylogenetic analysis of miracidia with differing
PZQ-susceptibilities
One hundred and twenty one susceptible and eight less
susceptible miracidia isolated from Kisorya Primary School
were successfully genotyped. There was no evidence that
less susceptible miracidia identified by in vitro PZQ testing
were related and therefore might constitute a genetic
cluster, as demonstrated using minimum spanning net-
work analysis and a consensus NJ tree between individ-
uals (Fig. 4).
Discussion
In host populations that are subject to frequent MDA,
the parasite population may be predicted to respond
with genetic changes. In the case of PZQ, the only drug
currently in distribution for schistosomiasis, the emer-
gence of S. mansoni strains that have lost susceptibility is
a major concern. With the current lack of specific genetic
markers for PZQ resistance [7], we rely on in vivo and in
vitro efficacy studies [8, 12] and population genetics using
neutral markers to understand parasite population re-
sponse to the selective pressures of wide-scale drug treat-
ment [13]. Here, for the first time, we combine results of
in vitro phenotypic monitoring with genotypic data to
understand the effect of five years of a national control
programme on S. mansoni parasite populations. Our re-
sults provide evidence of the presence of parasites with re-
duced susceptibility to PZQ in the parasite population five
years after the start of a National Control Programme
using PC with PZQ (and the anti-nematode albendazole),
as evidenced by an in vitro phenotypic assay based on lar-
val response to PZQ. However, there was no evidence that
parasites showing phenotypically reduced susceptibility
clustered together genetically, as would be expected fol-
lowing an ongoing selective sweep. Genetic data were also
used to estimate adult worm burden, demonstrating a
Fig. 2 Mean (± 95% confidence intervals) allelic richness (a) and expected (b) and observed heterozygosity (c) for the parasite infrapopulations of
individual children, adjusted for child age and sex and miracidial sample size, at two schools near Lake Victoria in 2005, 2006 and 2010
Fig. 3 Minimum spanning distance calculated using Edwards Cavelli-
Chord distance between parasite infrapopulations collected in two
schools (Bukindo Primary School, Ukewere Island and Kisorya Primary
School, Mara District) in 2005, 2006 and 2010
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reduction of worm load over time, despite little evidence
of long term reduction in parasite infection intensity. Gen-
etic diversity of infections did not reduce further over time
but there was evidence of change in the parasite popula-
tions in their genetic composition.
Prevalence and infection intensity of schistosomiasis
remained high at both study sites, although infection in-
tensity was significantly lower at Bukindo School on
Ukewere Island, compared to the mainland school,
Kisorya. Both schools received school-based PC in 2005
and 2007 under the National Control Programme, but
Bukindo additionally received community-wide PC for
all individuals over five years old in 2008 and 2009. Drug
efficacy in terms of egg reduction or cure rate immedi-
ately after treatment was not measured, such that these
schools had the same treatment history as the wider
population undergoing schistosomiasis control. The tem-
poral trends in the prevalence and intensity data suggest
that the PC treatments were not having a major impact
on the longer-term prevalence and intensity, possibly due
to rapid re-infection in this high transmission area. It
should be noted, however, that there is wide heterogeneity
in individuals’ schistosomiasis infection levels, and this
study was not powered to detect changes in prevalence
and infection intensity following MDA treatment, for
which much larger samples sizes are required (see e.g.
[30]). Indeed, a key finding of this study is that moni-
toring of infection intensity using egg output may have
additional problems above the widely reported low sen-
sitivity of Kato-Katz [10], namely that we report non-
linear relationships between adult worm burden and
egg output, that may also be influenced by treatment
history. We used parentage analysis to estimate the adult
worm burden from offspring genetic data, a technique
widely used to estimate population sizes in conservation
science, but with more restricted use in parasite biology
([31], but see, e.g. [32, 33]). Our results suggest that des-
pite no evidence of a reduction in mean infection inten-
sity, adult worm populations may indeed be declining,
masked by the fact that their egg output per worm pair
may be increasing, resulting in a lack of significant change
in mean infection intensity and therefore completely
undetected by the standard Kato-Katz techniques. The
reduced worm numbers resulted in a higher average
parasite reproductive success (measured as mean egg
output per adult worm pair) for parasite populations
following MDA, and could indicate the relaxation of
density-dependent constraints following successful kill-
ing of adult worms by PZQ. Density dependence may
thereby potentially be contributing to population per-
sistence and resilience, and complicating the monitor-
ing of chemotherapy success. Demonstration of the
existence of density-dependence in natural schistosome
populations is difficult due to non-accessibility of adult
worms due to their location in the blood vessels of the
mesenteric system around the intestine (S. mansoni) or
bladder (S. haematobium) and the only data that cur-
rently exists for human populations is from a single
autopsy study [14], thus population genetic data and
parentage analysis is a useful addition to this field. A
drawback is evidently that worms are not directly ob-
served, and thus the reliability of the data is hard to
prove, being dependent on the reliability of algorithms
for inferring parentage. This is a particular challenge in
Table 3 Pairwise FST between Schistosoma mansoni component populations and within-child Schistosoma mansoni infrapopulations
at two schools in Lake Victoria region of Tanzania in April 2005, April 2006 and July 2010
Bukindo 2005 Bukindo 2006 Bukindo 2010 Kisorya 2005 Kisorya 2006 Kisorya 2010
Pairwise FST between schools and years (component populations)
Bukindo 2005 na
Bukindo 2006 0.023 na
Bukindo 2010 0.064 0.096 na
Kisorya 2005 0.004 0.023 0.061 na
Kisorya 2006 0.023 0.022 0.095 0.017 na
Kisorya 2010 0.069 0.064 0.003 0.064 0.098 na
Mean of between infrapopulation FST
Bukindo 2005 0.031
Bukindo 2006 0.047 0.028
Bukindo 2010 0.076 0.109 0.012
Kisorya 2005 0.026 0.044 0.075 0.024
Kisorya 2006 0.039 0.019 0.098 0.034 0.012
Kisorya 2010 0.082 0.113 0.012 0.077 0.102 0.007
Overall mean between infrapopulation FST 0.048
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schistosomiasis where asexual reproduction in the
intermediate snail host may result in the existence of
clonal adult worms within individual human hosts.
However, there is little evidence that the proportion
and/or distribution of clonal adult worms would change
over time, therefore supporting our interpretations. In
particular, we did not see any changes in the relation-
ship of observed and expected heterozygosity which
might reflect changes in parasite mating behaviour, in-
dicative of an increase in the presence of clonal adult
worms. The results of this study, however, do suggest
that further investigation of parentage techniques, per-
haps using more molecular markers, and the consider-
ation of density-dependent factors in mathematical
modelling of treatment impact [11] is warranted. Such
data will be of particular importance should drug resist-
ance arise, as parasites surviving treatment, will have
the density-dependent pressures reduced and the sur-
viving more resistant strains may rapidly increase in
their proportional contribution to the gene pool.
Clustering, hierarchical FST and pairwise FST analyses
confirmed that parasite populations had changed over
the five-year time period since the baseline collections.
Re-analysis confirmed that a reduction in genetic diver-
sity was seen between the first and second collections,
but later collections showed no further reduction in di-
versity. One concern from the original study was that a
reduction in parasite diversity may suggest the selection
of parasite sub-populations able to survive MDA treat-
ment. Thus a further aim of this study was to consider
whether we were able to detect strains that are less sus-
ceptible to PZQ. We used an in vitro larval behaviour
assay, which is positively correlated with in vivo treat-
ment success [12]. We demonstrated that 6% of mira-
cidia were of “resistant or less susceptible”, normal
phenotype despite in vitro drug exposure, but 94% had a
contracted shape and therefore were susceptible to PZQ.
A similar percentage was also shown in the Ugandan
study [12], and this correlates well with the approximate
fraction of people that did not respond at a population
level in more recent studies in Uganda who had previ-
ously received 1–5 PZQ treatments [8]. Although a few
“resistant” miracidia were detected, one would still clas-
sify the overall schistosome population as susceptible,
since Liang and colleagues determined that PZQ-
sensitive worm strains from Puerto Rico, Kenya and
Egypt produced 67–100% of miracidia which responded
to in vitro PZQ exposure with phenotypic changes [34].
Indeed, using population genetic analysis, we investi-
gated whether the in vitro identified less susceptible
miracidia clustered into a group of genetically related
miracidia. However, no clustering was observed using
the neutral markers in this study, suggesting that these
parasites were not closely genetically related. The lack of
relatedness argues against a selective sweep of a small
number of “resistant” strains in this population, but ra-
ther supports the existence of a significant minority of
independently evolving populations with an existing low
susceptibility to PZQ. Therefore, we do not have evi-
dence of an observed impact of PZQ treatment on the
selection of resistant phenotypes in this study area.
However, despite these promising findings, we did have
some cause for concern. Although in vitro testing would
classify this Tanzanian S. mansoni population as suscep-
tible to PZQ, it was noted that all of the susceptible
miracidia responded with a tadpole shape, indicative of
intermediate susceptibility, rather than a dumbbell shape
associated with full susceptibility, in contrast to samples
from Uganda which consisted of equal proportions of
tadpole and dumbbell shapes, i.e. a mixture of inter-
mediately and fully susceptible [12]. Moreover, the study
by Crellen et al. [8], identified evidence of a reduction in
efficacy (about 10% reduction) only in populations that
had received 8 or 9 rounds of PC. Due to the key
Fig. 4 Genetic similarity of individual parasites subject to in vitro
parasite testing using Edwards Cavelli-Chord distance and visualised
using a neighbour-joining (NJ) phenogram. A consensus tree from
100 bootstrap repetitions is shown. Arrows show the presence of
individuals with reduced susceptibility to PZQ in vitro
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importance of continued PZQ efficacy to the success
of these highly important control programmes, which
are currently protecting millions of people from severe
disease, we suggest that continued long-term monitor-
ing of PZQ efficacy and the genetics of schistosome
populations using larger sample sizes, and across wider
geographic areas, are required. Although we found no
evidence of genetic relatedness and shared identity be-
tween individuals with low natural susceptibility to
PZQ using neutral markers, comparison of individual
miracidia with varying in vitro susceptibility using
whole genome sequencing may identify areas of the
genome that may be directly related to PZQ action and
confirm if single or multiple modes of action are re-
sponsible for increasing tolerance [8]. Such studies will
also be critical for the identification of molecular
markers associated with PZQ resistance and suscepti-
bility and thus allow us to directly monitor the effect
of MDA and varying treatment regimes on schisto-
some populations across the required wide geographic
area.
Conclusions
This study revisited two schools in the Lake Victoria
area of Tanzania five years after the introduction of a
National Control Programme to conduct follow-up
studies of the epidemiology and population genetics of
S. mansoni populations that had been investigated be-
fore treatment began, and six months after, the first
school-based PC treatment [13]. Using the same experi-
mental set-up as the original study, we identified no
further decrease in the intensity or genetic diversity of
S. mansoni infections within school children but ob-
served density-dependent effects on the worm popula-
tion following treatment, which would urge caution in
interpreting infection intensity results as measured by
egg output. Our longitudinal analysis showed further
changes in the genetic make-up of schistosome popula-
tions which also included miracidia that were less sus-
ceptible to PZQ in vitro. However, we found no evidence
of genetic similarity between parasites that were less
susceptible to PZQ in vitro, as might be expected given
a large scale selective sweep and the overall S. mansoni
population at the study sites in Tanzania’s Lake Victoria
region still be classified as susceptible in 2010. We sug-
gest that monitoring of the parasite population and its
responsiveness towards PZQ is strongly advisable and
that studies on cost-of-resistance [35] in natural schis-
tosome populations should be conducted using parent-
age analysis to estimate parasite reproductive success
and any trade-offs between resistance and other fitness
traits since this could potentially help prepare us for
the management of potentially emerging PZQ-resistant
strains.
Additional file
Additional file 1: Figure S1. Location of study sites in Tanzania. In
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(Ukerewe District, Mwanza Region). The second school studied was
Kisorya Primary School (Bunda District, Mara Region) which is located on
the mainland. Both schools are in close proximity to the lakeshore. (TIFF
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